Seismic Therapeutic Appoints Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy
Retrieved on:
Wednesday, April 13, 2022
Biotechnology, Pharmaceutical, Health, Leadership, Drug development, CEO, BS, SM, Biotechnology, Northern Power Systems, Market for corporate control, Biogen, MIT Sloan School of Management, Relay, MBA, System, Babson College, Advanced Technology Program, Pandion, Operation, CPA, R, Ernst & Young, Doctor of Philosophy, Machine learning, Program, Goal, Patient, Growth, CMGI, Grove City College, Nasdaq, Therapy, Protein engineering, Proteostasis, Degenerative disease, Seismology, Heather Vitale, Partnership, Senior, Master of Science in Management, Management, Finance
Seismic Therapeutic , Inc., a biotechnology company advancing machine learning for immunology drug development, today announced the appointment of Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy.
Key Points:
- Seismic Therapeutic , Inc., a biotechnology company advancing machine learning for immunology drug development, today announced the appointment of Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy.
- It is exciting to be part of such a talented team at Seismic focused on a new drug development paradigm, said Mr. Larson.
- Eric Larson brings nearly 30 years of financial leadership experience with private and public companies across multiple industries.
- Prior to joining Seismic, Eric was Vice President of Finance at Pandion Therapeutics where he built the finance and accounting infrastructure in support of its transition to a Nasdaq-listed public company.